Financhill
Sell
42

CRBU Quote, Financials, Valuation and Earnings

Last price:
$1.90
Seasonality move :
-18.24%
Day range:
$1.84 - $1.90
52-week range:
$0.66 - $3.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
18.62x
P/B ratio:
1.23x
Volume:
719.5K
Avg. volume:
3.6M
1-year change:
-12.62%
Market cap:
$174.8M
Revenue:
$10M
EPS (TTM):
-$1.70

Earnings Data

Next earnings date for CRBU
Mar 17
2026
Most recent earnings per share
-$0.30
Missed by $0.30
(Nov 12/2025)
Consensus Estimate
--
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CRBU Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/17/2026 Q4 $1.9M -- -- -- --
11/12/2025 Q3 $1.9M $2.2M -$0.30 -- --
08/12/2025 Q2 $1.6M $2.7M -$0.58 -$0.42 -$0.16
05/06/2025 Q1 $1.4M $2.4M -$0.43 -$0.45 $0.01
03/10/2025 Q4 $1.8M $2.1M -$0.39 -$0.40 $0.01
11/06/2024 Q3 $3.1M $2M -$0.38 -$0.45 $0.07
08/06/2024 Q2 $3M $3.5M -$0.42 -$0.44 $0.02
05/07/2024 Q1 $2.4M $2.4M -$0.46 -$0.38 -$0.08
03/11/2024 Q4 $4.6M $3.6M -$0.39 -$0.35 -$0.04
11/07/2023 Q3 $2.6M $23.7M -$0.12 -$0.36 $0.24
08/08/2023 Q2 -- $3.8M -$0.48 -- --
05/09/2023 Q1 -- $3.5M -$0.46 -- --
03/09/2023 Q4 -- $3.7M -$0.44 -- --
11/08/2022 Q3 -- $3.3M -$0.44 -- --
08/09/2022 Q2 -- $4.2M -$0.44 -- --
05/09/2022 Q1 -- $2.7M -$0.32 -- --
03/21/2022 Q4 -- $2.6M -$0.31 -- --
11/09/2021 Q3 -- $4M -$0.35 -- --
09/02/2021 Q2 -- $1.5M -$0.24 -- --
03/31/2021 Q1 -- $1.6M -$0.22 -- --
12/31/2020 Q4 -- $984K -$0.53 -- --
09/30/2020 Q3 -- $1.2M -$0.13 -- --
06/30/2020 Q2 -- $8.5M -$0.03 -- --
03/31/2020 Q1 -- $1.7M -$0.16 -- --

Caribou Biosciences, Inc. Earnings Questions

  • How Much did Caribou Biosciences, Inc. Generate in Revenue Last Quarter?

    Caribou Biosciences, Inc. reported $2.2M worth of top line sales in its most recent quarter.

  • Did Caribou Biosciences, Inc. Beat Earnings Last Quarter?

    Caribou Biosciences, Inc. announced earnings per share of -$0.30 which represents a miss of analyst forecast a -- per share.

  • Is Caribou Biosciences, Inc. Profitable?

    Caribou Biosciences, Inc. reported $1.6M that represents $0.02 per share over the last quarter.

  • What is the Analyst Consensus for Caribou Biosciences, Inc. EPS Next Year?

    Caribou Biosciences, Inc.'s earnings are forecast to decrease from -$1.65 per share to -$1.68 per share next year representing a decrease of -0.66%.

  • When is Caribou Biosciences, Inc.'s Earnings Date?

    Caribou Biosciences, Inc.'s next earnings date is March 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Stock Ideas

Buy
64
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
60
OLMA alert for Dec 10

Olema Pharmaceuticals, Inc. [OLMA] is up 15.35% over the past day.

Buy
84
TSAT alert for Dec 10

Telesat Corp. [TSAT] is up 3.07% over the past day.

Buy
54
GDXU alert for Dec 10

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 4.83% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock